Bay Shore Trust
CIK: 0001986593
Bay Shore Trust's purchase track record
Bay Shore Trust has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/13/2024 | TELO | $966K | -10.1% | -35.9% | +9.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| TELO | ▲ Buy | Open Market | 49,000 | $343K | 2/13/2024 | View on chart |
| TELO | ▲ Buy | Open Market | 49,000 | $343K | 2/13/2024 | View on chart |
| TELO | ▲ Buy | Open Market | 40,000 | $280K | 2/13/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Telomir Raises ~$5.6M via PIPE Financing
Telomir Pharmaceuticals announced it will raise about $5.6 million by issuing new common shares in a private placement. The capital will support the company’s research and development efforts, potentially helping to advance its drug pipeline. The share issuance may increase the number of shares outstanding, which could affect the stock price and dilution.
Telomir Raises ~$5.6M via PIPE Financing. Telomir Pharmaceuticals announced it will raise about $5.6 million by issuing new common shares in a private placement. The capital will support the company’s research and development efforts, potentially helping to advance its drug pipeline. The share issuance may increase the number of shares outstanding, which could affect the stock price and dilution.